期刊文献+

Livin与EGFR、VEGF在结直肠癌中的表达及相关性研究 被引量:2

Expression of Livin, EGFR and VEGF in Colorectal Cancer and Their Correlation
下载PDF
导出
摘要 【目的】探讨Livin基因在结直肠癌中的表达及其与表皮生长因子受体(EGFR )、血管内皮生长因子(VEGF)的相关性。【方法】采用免疫组织化学染色方法检测结直肠癌、大肠正常黏膜组织各50例中Livin、EG‐FR、VEGF的表达,并分析Livin表达与EGFR、VEGF的相关性。【结果】结直肠癌组织中Livin蛋白的阳性表达率明显高于大肠正常黏膜组织( P <0.01);Livin蛋白阳性表达率与淋巴结转移及Duke分期有关,而与结直肠癌患者的年龄、性别、分化程度无关;结直肠癌组织中 EGFR蛋白的阳性表达率明显高于正常黏膜组织( P <0.01);EGFR阳性表达率与结直肠癌中肿瘤的分化程度、Duke分期及淋巴结转移密切相关,与结直肠癌患者的年龄、性别无统计学意义;大肠正常黏膜组织中VEGF的阳性表达率低于结直肠癌组织中VEGF的阳性表达率( P <0.01),其差异有统计学意义,VEGF蛋白表达与结直肠癌患者的性别、年龄、肿瘤分化程度无关,与肿瘤的Duke分期及有无淋巴结转移有关;在结直肠癌组织中Livin蛋白阳性表达与 EGFR ,VEGF蛋白阳性表达无相关性,而EGFR蛋白阳性表达与VEGF蛋白阳性表达呈正相关。【结论】Livin在结直肠癌组织中过表达,阳性表达率明显高于大肠正常黏膜组织,推测Livin促进了结直肠癌的发生、发展。EGFR、VEGF蛋白在结直肠癌组织中表达呈正相关,推测EGFR、VEGF在结直肠癌的发生发展过程中起着至关重要的作用。 [Abstract ][Objective]To explore the expression of Livin in colorectal cancer and its correlation with epidermal growth factor receptor(EGFR) and vascular endothelial growth factor (VEGF) .[Methods] The expressions of Livin , EGFR and VEGF in 50 cases of colon cancer and 50 cases of normal colorectal mucosa were detected by immunohisto‐chemistry staining .The correlation of Livin with EGFR and VEGF was analyzed .[Results] The positive expression rate of Livin in colorectal cancer was obviously higher than that in normal colorectal mucosa ( P〈0 .01) .The positive expres‐sion rate of Livin protein was related to lymph node metastasis and Duke stage ,but not related to the age ,sex and differ‐entiation degree of patients with colorectal cancer .The positive expression rate of VEGF in normal colorectal mucosa was lower than that in colorectal cancer ,and there was significant difference ( P 〈0 .01) .The expression of VEGF protein was not related to the sex ,age and tumor differentiation degree ,but related to Duke stage and lymph node metastasis . The positive expression of Livin protein in colorectal cancer was not related to the positive expression of EGFR and VEGF ,but the positive expression of EGFR was positively correlated with the positive expression of VEGF .[Conclusion]Livin is over expressed in colorectal cancer .The positive expression of Livin in colorectal cancer is obviously higher than that in normal colorectal mucosa which infers that Livin promotes the occurrence and development of colorectal cancer . EGFR expression in colorectal cancer is positively correlated with VEGF expression which infers that EGFR and VEGF play very important role in the occurrence and development of colorectal cancer .
出处 《医学临床研究》 CAS 2014年第10期1885-1888,共4页 Journal of Clinical Research
基金 2013年河北省廊坊市科技支撑计划项目(项目编号2013013006)
关键词 结直肠肿瘤/病理学 受体 表皮生长因子/代谢 血管内皮生长因子A/代谢 Colorectal Neoplasms/PA Receptor,Epidermal Growth Factor/ME Vascular Endothelial Grow th Factor A/ME
  • 相关文献

参考文献10

二级参考文献31

  • 1何剪太,李珍发,张阳德,邓丽萍,王吉伟,潘一峰.凋亡抑制因子Livin在大肠癌中的表达意义[J].中国现代医学杂志,2007,17(6):654-657. 被引量:26
  • 2刘海波,陈涛,孔垂泽.凋亡抑制蛋白家族新成员LIVIN的研究进展[J].医学综述,2007,13(7):495-497. 被引量:3
  • 3Choi J, Hwang YK, Sung KW, et al. Expression of Livin, an antiapoptot- ic protein, is an independent favorable prognostic factor in childhood a- cute lymphoblastic leukemia[J]. Blood, 2007, 109(2):471-477. 被引量:1
  • 4Kasof GM, Gomes BC. Livin, a novel inhibitor of apoptosis protein familly member[J]. Biol Chem,2001,276(5 ):32-38. 被引量:1
  • 5Ka H, Hunt JS. Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas[J]. Am J Pathol, 2003,163(2) 413-422. 被引量:1
  • 6Zhenping ZHU.Targeted cancer therapies based on antibodies directed against epidermal growth factor receptor:status and perspectives[J].Acta Pharmacologica Sinica,2007,28(9):1476-1493. 被引量:11
  • 7Baiocchi G, Lopes A, Coudry RA, et al. ErbB family immunohisto- chemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery[ J ]. Int J Colorectal Dis, 2009,24 (9) :1059 - 1068. 被引量:1
  • 8Li Q, Wang D, Li J, et al. Clinicopathological and prognostic signifi- cance of HER - 2/neu and VEGF expression in colon carcinomas [ J ]. BMC Cancer,2011,11:277 - 282. 被引量:1
  • 9Doger FK, Meteoglu I, Tuncyurek P, et al. Does the EGFR and VEGF expression predict the prognosis in colon cancer [ J ] ? Eur Surg Res,2006,38(6) :540-544. 被引量:1
  • 10Wang J,Hollingshead J,E1 - Masry N,et al. Expression of EGFR,HER2, Phosphorylated ERK and phosphorylated MEK in colonic neoplasms of familial adenomatous polyposis patients [ J ]. J Gastroi- ntest Cancer,2011,10 : 12. 被引量:1

共引文献11

同被引文献46

  • 1王利娟,田园,高积勇.宫颈癌预后与表皮生长因子受体蛋白表达关系[J].中国妇幼健康研究,2006,17(4):280-282. 被引量:6
  • 2刘俊丽,陈元,蔡煜,张敏.选择性EGFR酪氨酸激酶抑制剂吉非替尼对宫颈癌离体细胞的放射增敏作用[J].肿瘤防治研究,2007,34(7):480-482. 被引量:8
  • 3J ema A. Bray F. FerlayJ Global cancer statistics[J]. Ca CancerJ Clin.2011.61(2) :69-90. 被引量:1
  • 4Pecore IIi S.Pasinetti Bv Angioli Rver al. Systemic therapy for gynecological neoplasms: ovary. cervix. and endometrium[J]. Cancer Chemother Bioi Response Modif. 2005,22: 515-544. 被引量:1
  • 5Cerciello F. Riesterer O. Sherweil M, et al, Is EGFR a moving target during radiotherapy of carcinoma of the uterine cervix[J]. Gynecol On col, 2007 .106(2) :394-399. 被引量:1
  • 6Vosmik M. LacoJ, Sirak I, et al. Prognostic significance of human papilloma virus (HPV) status and expression of selected markers (HER2/neu , EGFR , VEGF, CD34, p63, p53 and Ki67/ MIB-l) on outcome after Cchemo-lradiotherapy in patients with squamous cell carcinoma of uterine cervix[J]. Pathol On colo Res.2014.20(1):131-137. 被引量:1
  • 7Perez-Regadera I .Sanchez-Munnoz AvDe-la-Cruz I .et al. Impact of epidermal growth factor receptor expression on disease-free survival and rate of pelvic relapse in patients with advanced cancer of the cervix treated with chemoradiotherapy[J]. Am I Clin Onco1.2011.34(4) :395-400. 被引量:1
  • 8Iida K, Nakayama K, Rahman MT, et al. EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target[J]. Br I Cancer.2011,105(3) :420-427. 被引量:1
  • 9Giordano G.D' Adda T,Dal Bello B,et al. Clinicopathologic implications of the epidermal growth factor receptor, cyclcoxygenase 2 expression, and human papillomavirus status in squamous cell carcinoma of the uterine cervix in the elderly[J]. Int I Gynecol Cancer, 2011 ,21(2) :337-348. 被引量:1
  • 10Farley I, Sill MW, Birrer M, et al. Phase II study of cisplatin plus cetuximab in advanced. recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study[J]. Gynecol Oncol,2011 ,121(2) :303-308. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部